Nowadays, multifunctional aptamer molecules are widely studied biomedical class among scientists across the globe. Due to its unique chemistry and potential advantages compared to currently available drugs (i.e. antibodies), aptamer became one of the most budding market for the future period. For example, according to the scientists, antibodies take around 7–15 years for production and cost more than USD 4 billion with average failure rate of 85%. Unlike antibodies, aptamers are directly tested in animal model i.e. in-vivo test (bypassing in-vitro test entirely) which eliminate majority of benchmark testing during the production of aptamers. Because of this, production of aptamers save several years and approximately 35% of research and development cost compared to antibodies. This advantage of aptamers has attracted more and more attention among researchers within life science and biomedical applications. Other advantages such as easy digestion by enzyme, less risk to provoke undesired immune response, high thermal stability, and cost efficiency as compared to the antibody regime boost the uptake of aptamers. Such benefits will help aptamers to become one of the most demanding research field during the coming years which will establish healthy platform for the market growth.

The study of the integrated quantum optical circuits in this report emphasizes on various material types, and corresponding applications. This device uses light instead of electricity for signal processing and computing. The market size revenue considered in the report is revenue earned by companies by selling integrated quantum optical circuits. From application perspective, the report analyzes the market according to optical fiber communication, optical sensors, bio medical, quantum computing, and others.

逐步深入，如何从“策略+指标”衡量SaaS 企业价值？科创板正式获批，后续布局将加速进行。2018 年美股收益率TOP10中云计算几近占据半壁江山，全球IT 支出亦向云计算转变。2019 年，To B 为发展大方向，“硬科技”为发展核心点，在行业背景驱动下，我们预测，云计算将延续2018 年的热度持续上升。我们聚焦SaaS 领域，由远及近分析企业价值，为投资者梳理筛选优质SaaS 公司的方法论。